KARPAS 620 Human Plasma Cell Leukaemia cell line

KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research.
Technology No. CL14

KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

Publications:

Nacheva et al. (1990). Br J Haematol 74, 70–76

Drexler and Matsuo (2000). Leuk Res 24, 681–703



  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    KARPAS 620 Human Plasma Cell Leukaemia cell line.pdf
    DOWNLOAD
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Internal Research Licence - 1 Year
1-year non-exclusive licence agreement for use of the Karpas 620 Cell Line for internal research only.

Term: 12 months

Price on approval

Questions about this technology?
Contact us

Sign up to our newsletter

If you would like to keep up to date with the latest opportunities, please sign up to our newsletter.